z-logo
Premium
Guillain–Barré syndrome associated with resistant cytomegalovirus infection after face transplantation
Author(s) -
Alhefzi M.,
Aycart M.A.,
Bueno E.M.,
Kueckelhaus M.,
Fischer S.,
Snook R.J.,
Sharfuddin A.A.,
Hadad I.,
Malla P.,
Amato A.A.,
Pomahac B.,
Marty F.M.
Publication year - 2016
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12516
Subject(s) - medicine , cytomegalovirus , cytomegalovirus infections , transplantation , cytomegalovirus infection , guillain barre syndrome , virology , immunology , herpesviridae , virus , human cytomegalovirus , viral disease
A 39‐year‐old male, who received a facial allograft (cytomegalovirus [ CMV ] donor‐seropositive, recipient‐seronegative), developed multidrug‐resistant CMV infection despite valganciclovir prophylaxis (900 mg/day) 6 months post transplantation. Lower extremity weakness with upper and lower extremity paresthesias developed progressively 11 months post transplantation, coinciding with immune control of CMV . An axonal form of Guillain–Barré syndrome was diagnosed, based on electrophysiological evidence of a generalized, non‐length‐dependent, sensorimotor axonal polyneuropathy. Treatment with intravenous immunoglobulin led to complete recovery without recurrence after 6 months.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom